LEXX icon

Lexaria Bioscience
LEXX

Overview Fund Activity

25 hedge funds and large institutions have $3.23M invested in Lexaria Bioscience in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$361K
2
RJFSA
2
Raymond James Financial Services Advisors
Florida
$144K
3
State Street
3
State Street
Massachusetts
$143K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$309K
5
ACM
5
ADAR1 Capital Management
Texas
$96.7K

Top Sellers

1
ICM
1
Invenomic Capital Management
Massachusetts
$1.72M
2
CAC
2
Cowen and Company
New York
$0
3
CCM
3
Connective Capital Management
California
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$57.6K
5
TRCT
5
Tower Research Capital (TRC)
New York
$9.81K
Name Market Value Shares Shares
Change 		Shares
Change %
CAC
26
Cowen and Company
New York
– – -256,327 Closed
CCM
27
Connective Capital Management
California
– – -60,000 Closed
UBS Group
28
UBS Group
Switzerland
– – -4,532 Closed
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
– – -1,019 Closed
SIS
30
Sound Income Strategies
Florida
– – -22 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
1
2